Open AccessT031 (0110) FIVE‐YEAR PROGRESSION‐FREE SURVIVAL OUTCOMES FROM A PIVOTAL PHASE 3 STUDY OF CONSOLIDATIVE BRENTUXIMAB VEDOTIN AFTER AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH HODGKIN LYMPHOMA AT RISK OF RELAPSE OR PROGRESSION (AETHERA)
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547954.06005.08
Subject(s) - brentuximab vedotin , oncology , medicine , autologous stem cell transplantation , hodgkin lymphoma , lymphoma